These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3514325

  • 1. Persistence of polymicrobial abscesses in the poorly controlled diabetic host.
    Bessman AN, Sapico FL, Tabatabai M, Montgomerie JZ.
    Diabetes; 1986 Apr; 35(4):448-53. PubMed ID: 3514325
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD, Kao J, Houston K.
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of anaerobic bacteria in intra-abdominal septic abscesses in mediating septic control of skeletal muscle glucose oxidation and lactic acidemia.
    Vary TC, Siegel JH, Tall B, Morris JG.
    J Trauma; 1989 Jul; 29(7):1003-13; discussion 1013-4. PubMed ID: 2664200
    [Abstract] [Full Text] [Related]

  • 6. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE, Gyssens IC, Goessens WH, Mouton JW, Oyen WJ, van der Meer JW, Verbrugh HA.
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [Abstract] [Full Text] [Related]

  • 7. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL, Arland LA, Simmons RL, Rotstein OD.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [Abstract] [Full Text] [Related]

  • 8. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD, Kao J.
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I, Ledney GD.
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergy of Bacteroides fragilis and Escherichia coli in the induction of KC gene expression in mouse peritoneal tissues.
    Kim JM, Kim YJ, Cho YJ.
    Scand J Infect Dis; 2000 Feb; 32(6):643-9. PubMed ID: 11200375
    [Abstract] [Full Text] [Related]

  • 15. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M, McDonald PJ.
    Chemotherapy; 1983 Feb; 29(3):225-9. PubMed ID: 6347547
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathogenicity of enterococci in a rat model of fecal peritonitis.
    Matlow AG, Bohnen JM, Nohr C, Christou N, Meakins J.
    J Infect Dis; 1989 Jul; 160(1):142-5. PubMed ID: 2543707
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP, Vince T, Bloom R, Gregory FJ, Hung PP.
    Drugs Exp Clin Res; 1987 Jul; 13(8):493-6. PubMed ID: 3322752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.